To the full analysis
Innoviva stock: growth
INVAInnoviva reported $425.13M in revenue for fiscal 2025, up 18.5% on the prior year, up 4.8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
17.6%
per year from 2006 to 2025, per share 16.8%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 4.8% | 22.9% | 17.6% |
| Revenue per share | 13.7% | 29.7% | 16.8% |
| Earnings | 3.9% | no data | no data |
| Earnings per share | 12.7% | no data | no data |
| Free cash flow | −9.8% | 33.8% | no data |
| Free cash flow per share | −2.2% | 41.2% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $19.59M | −$166.04M | −$110.5M |
| 2007 | $22M | −$160M | −$114.19M |
| 2008 | $23.1M | −$93.64M | −$100.94M |
| 2009 | $24.37M | −$85.3M | −$58.81M |
| 2010 | $24.22M | −$83.86M | −$76.01M |
| 2011 | $24.51M | −$115.34M | −$91.97M |
| 2012 | $5.61M | −$18.54M | −$130.54M |
| 2013 | $4.53M | −$170.7M | −$217.34M |
| 2014 | $8.43M | −$168.46M | −$131.41M |
| 2015 | $53.95M | −$18.76M | $10.12M |
| 2016 | $133.57M | $59.54M | $60.71M |
| 2017 | $217.22M | $134.14M | $141.75M |
| 2018 | $261M | $395.06M | $223.53M |
| 2019 | $261.02M | $157.29M | $257.45M |
| 2020 | $336.79M | $224.4M | $313.1M |
| 2021 | $391.87M | $265.85M | $362.51M |
| 2022 | $331.34M | $213.92M | $201.66M |
| 2023 | $310.46M | $179.72M | $140.65M |
| 2024 | $358.71M | $23.39M | $188.42M |
| 2025 | $425.13M | $271.17M | $186.43M |
Revenue by segment
How Innoviva, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Royalty56%
- Product40%
- Other4%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| Royalty | $311.65M | $238.85M | $241.73M | $236.48M | 55.6% |
| Product | $19.69M | $60.62M | $97.49M | $172.13M | 40.5% |
| Other | $0 | $11M | $19.49M | $16.52M | 3.9% |
| Total revenue | $331.34M | $310.46M | $358.71M | $425.13M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 6 Nov 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.